dexmedetomidine has been researched along with Prostatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, C; Li, Y; Wang, Y; You, Z; Zhang, H; Zhang, X | 1 |
| Gao, X; Gong, RJ; Li, YH; Xia, XQ; Yang, ZH; Yu, YB | 1 |
| Ip-Yam, PC; Ng, AT | 1 |
1 trial(s) available for dexmedetomidine and Prostatic Neoplasms
| Article | Year |
|---|---|
[Effects of low-dose dexmedetomidine combined with hydromorphone in postoperative analgesia and on the serum IL-6 and CRP levels of prostate cancer patients].
Topics: Analgesia; Dexmedetomidine; Humans; Hydromorphone; Interleukin-6; Male; Prostatic Neoplasms | 2021 |
2 other study(ies) available for dexmedetomidine and Prostatic Neoplasms
| Article | Year |
|---|---|
Chrysosplenol D can inhibit the growth of prostate cancer by inducing reactive oxygen species and autophagy.
Topics: Animals; Autophagy; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Prostatic Neoplasms; Reactive Oxygen Species | 2023 |
Epidural anesthesia with intravenous dexmedetomidine sedation in the successful anesthetic management of MRI-guided focused ultrasound ablation of early prostatic cancer.
Topics: Aged; Anesthesia, Epidural; Dexmedetomidine; Humans; Hypnotics and Sedatives; Magnetic Resonance Imaging; Male; Middle Aged; Prostatic Neoplasms; Ultrasonic Therapy; Ultrasonography | 2011 |